Stay updated on Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice says NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.4%

- Check7 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check35 days agoChange DetectedA new page revision entry for v3.7.0 has been added to the history. The previous revision v3.6.6 is removed from the list.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.6 was added to the record history and the previous v3.6.5 entry was removed. This updates the page's release notes to reflect the latest version of the documentation.SummaryDifference0.1%

- Check71 days agoChange DetectedThe history now records a new revision (v3.6.5). The previous revision (v3.6.4) has been superseded, indicating an update to the record's version history.SummaryDifference0.1%

Stay in the know with updates to Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page.